GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Chromadex Corp
Shares of Chromadex, the company behind the Niagen brand (a supplement for "healthy aging"), reflect the growth of the nutraceutical market. Its price trajectory depends on the results of scientific research, marketing efforts, and the ability to protect its intellectual property.
Share prices of companies in the market segment - Medical instruments
ChromaDex (NAGE), known for its product Niagen (nicotinamide riboside), researches and commercializes ingredients for healthy aging and cellular metabolism. We classify it as a "Medical Instruments" company. The chart below shows the dynamics of the nutraceuticals and dietary supplements sector.
Broad Market Index - GURU.Markets
AgeX Therapeutics is a biotech company focused on developing drugs to combat aging and age-related diseases. Its ambitious goals make it a component of the GURU.Markets index. The chart below shows how investors view this anti-aging sector.
Change in the price of a company, segment, and market as a whole per day
NAGE - Daily change in the company's share price Chromadex Corp
The volatility of Chromadex, a manufacturer of dietary supplements, reflects the state of the wellness industry. Change_co measures sensitivity to scientific research and consumer trends. This parameter is important for formulas on System.GURU.Markets that analyze companies in the nutraceuticals sector.
Daily change in the price of a set of shares in a market segment - Medical instruments
The medical devices sector, in which Chromadex Corp operates, is highly dynamic. This chart reflects the average volatility of the industry. It serves as a benchmark for assessing how sensitive Chromadex's dietary supplement ingredient business is to overall trends.
Daily change in the price of a broad market stock, index - GURU.Markets
ChromaDex is a biotech company focused on the research and commercialization of ingredients for healthy aging, specifically nicotinamide riboside. The chart below illustrates the volatility of the nutraceutical sector, highlighting the risks and potential associated with scientific research.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Chromadex Corp
Chromadex is the company behind the popularization of nicotinamide riboside (NR), an anti-aging ingredient. The company's stock price reflects consumer trends in the wellness sector, and its performance is part of a larger picture of the consumer market.
Annual dynamics of market capitalization of the market segment - Medical instruments
ChromaDex, through its Niagen product, is the market leader in NAD+ boosters, a popular anti-aging supplement. The company's success depends on scientific evidence and its ability to build a consumer brand. Its performance relative to the industry will reveal how much investors believe in the potential of this emerging nutraceutical segment.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
The ticker symbol NAGE belongs to N-able, not Chromadex. ChromaDex (CDXC), which produces Niagen supplements, is a consumer health company. Its stock performance is driven not by economics, but by scientific data and marketing success in promoting its product as an anti-aging treatment.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Chromadex Corp
Chromadex (Niagen), as a nutraceutical company, will depend on consumer demand for its value. Monthly fluctuations on the chart will reflect sales growth of its flagship product, Niagen, marketed as an anti-aging supplement, and advances in scientifically validating its properties.
Monthly dynamics of market capitalization of the market segment - Medical instruments
Chromadex Corp (NAGE) is focused on commercializing the healthy aging ingredient Niagen, positioned at the intersection of nutraceuticals and biotechnology. The biotech and medical development sector is highly sensitive to scientific breakthroughs and investor confidence. This chart illustrates how the market generally assessed the prospects of such innovative companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
ChromaDex sells science-based ingredients for healthy aging, such as Niagen. Its stock price is driven by growing consumer demand for health products and research confirming their effectiveness. It's a consumer health story driven by wellness trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Chromadex Corp
ChromaDex Corp. is focused on commercializing an ingredient for healthy aging. Weekly stock performance is driven by scientific research results, marketing success, and regulatory news in the dietary supplement industry, creating high volatility.
Weekly dynamics of market capitalization of the market segment - Medical instruments
ChromaDex Corp commercializes ingredients for healthy aging. Comparing its weekly performance with the consumer health sector will reveal its market position. The chart allows you to assess how scientific publications and marketing successes impact its stock relative to its larger, more diversified peers.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of Chromadex Corp, a dietary supplement company, seem to exist in a world of their own. Their performance is often driven by news about scientific research and marketing. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can move independently of the broader market.
Market capitalization of the company, segment and market as a whole
NAGE - Market capitalization of the company Chromadex Corp
The market capitalization chart of Chromadex (Niagen) tells the story of how the market evaluates the science of longevity and anti-aging. The company sells Niagen, a precursor to NAD+. Its dynamics reflect investors' faith or skepticism regarding the clinical data supporting the product's benefits and its commercial potential in the dietary supplement market.
NAGE - Share of the company's market capitalization Chromadex Corp within the market segment - Medical instruments
Chromadex Corp., through its flagship ingredient Niagen, is a pioneer in research into nicotinamide riboside (NR), a form of vitamin B3, for healthy aging. Its market share reflects its leadership in longevity science. The chart below shows the company's weight in the growing nutraceuticals and supplements market.
Market capitalization of the market segment - Medical instruments
ChromaDex, through its Niagen product, focuses on increasing levels of NAD+, a key coenzyme for cellular metabolism and aging. The chart below shows the overall market capitalization of the medical devices sector. It reflects the growing interest in nutraceuticals and longevity science, where ChromaDex is seeking to establish a leading position.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows the science of longevity in action. Chromadex (NAGE) is behind the commercialization of nicotinamide riboside (Niagen), a cellular energy-boosting ingredient. Its market cap is a barometer of consumer interest in healthy aging and anti-aging products.
Book value capitalization of the company, segment and market as a whole
NAGE - Book value capitalization of the company Chromadex Corp
Chromadex's book value is derived from its intellectual property (IP) for the ingredient Niagen (nicotinamide riboside) and the capital for its research and commercialization. This is the scientific foundation for a healthy aging business. The chart shows how the company built its capital base by advancing its key patented product.
NAGE - Share of the company's book capitalization Chromadex Corp within the market segment - Medical instruments
Chromadex (Niagen) is the company behind a popular longevity supplement. Its business model is lightweight: it owns the patents and brand, but often outsources production. The chart shows a modest share of physical assets, as its strength lies in science and marketing, not manufacturing.
Market segment balance sheet capitalization - Medical instruments
Developing and selling dietary supplements like Chromadex's is moderately capital-intensive. Compared to the pharmaceutical sector's assets, its model, based on Niagen's patent, requires R&D and quality control, but can be "easier" than traditional pharmaceuticals due to outsourcing of production.
Book value of all companies included in the broad market index - GURU.Markets
ChromaDex's (parent company Niagen Bioscience) assets include laboratories and manufacturing facilities for the development and study of nicotinamide riboside (NR), a component associated with cellular health and longevity. The book value reflects the company's scientific and manufacturing base in the nutraceuticals niche. The chart illustrates its scale within this industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Chromadex Corp
ChromaDex is valued by the market above the value of its laboratories. Investors are paying a premium for its patents on nicotinamide riboside (NR), a popular ingredient in anti-aging supplements, and for the growth potential of this market. The chart demonstrates faith in its science and brand.
Market to book capitalization ratio in a market segment - Medical instruments
ChromaDex is the company behind the anti-aging ingredient Niagen. Its value lies in its science and brand. This chart shows how investors value the nutraceutical market potential and its intellectual property, placing a high premium on its tangible assets.
Market to book capitalization ratio for the market as a whole
ChromaDex (a Niagen brand) produces and markets ingredients and consumer products for healthy aging, including nicotinamide riboside. The company's value lies in its patents and scientific research. This metric reflects the market's appreciation of the potential of nutraceuticals at the intersection of science and consumer products, and its belief in the long-term trend toward healthy living.
Debts of the company, segment and market as a whole
NAGE - Company debts Chromadex Corp
Chromadex (Niagen) is in the commercialization phase of its health and longevity products. The company is raising capital, including debt, to fund research, marketing, and distribution expansion. This chart illustrates the financial needs of a growing company in a new and competitive nutraceutical niche seeking to prove the scientific value of its products.
Market segment debts - Medical instruments
ChromaDex is the company behind Niagen, a patented form of nicotinamide riboside (NR), an ingredient in products that promote healthy aging. Situated at the intersection of science and consumer products, the company invests in clinical research and marketing. This chart shows how ChromaDex is funding its efforts to create and market this new category of dietary supplements.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Chromadex Corp
Chromadex, known for its NAD+-boosting product Niagen, operates in the nutraceutical and healthy aging industries. The development, clinical trials, and marketing of new products require significant investment. This chart shows how the company uses debt to fund growth and research, reflecting its bet on future demand.
Market segment debt to market segment book capitalization - Medical instruments
ChromaDex Corporation is the company behind the commercialization of nicotinamide riboside (NR), a compound associated with health and longevity. This chart shows how the company funds its research and marketing, comparing its debt load to the overall market capitalization of the entire biotech and nutraceuticals sector.
Debt to book value of all companies in the market
ChromaDex Corp, known for its cellular health product Niagen, operates at the intersection of nutraceuticals and biotechnology. Growth in the consumer market and scientific research require investment. Does the company finance this through debt? This chart of total market debt helps assess the sustainability of its financial strategy and its independence from creditors.
P/E of the company, segment and market as a whole
P/E - Chromadex Corp
ChromaDex is a biotechnology company focused on the research and commercialization of nicotinamide riboside (NR), a healthy aging ingredient known under the brand name Niagen. This chart shows how investors view the scientific data and commercial potential of its product in the dietary supplement and nutraceutical market.
P/E of the market segment - Medical instruments
ChromaDex is a bioscience company focused on healthy aging, best known for its ingredient Niagen (nicotinamide riboside), which increases NAD+ levels in the body. This chart shows the average rating for medical device manufacturers, helping to understand how the market views ChromaDex's scientific developments and commercial potential.
P/E of the market as a whole
ChromaDex Corp., through its Niagen product, focuses on the healthy aging supplement market. Does the company's valuation reflect a general interest in the health and longevity industry or a unique focus on the scientific validity of its product and its ability to protect its intellectual property? This chart helps separate the general trend from a specific story.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Chromadex Corp
ChromaDex is the company behind Niagen, a patented form of nicotinamide riboside that promotes cellular metabolism and healthy aging. This chart shows market expectations for sales growth of this nutraceutical. Future profits depend on scientific research confirming its benefits and expanded distribution.
%20P%2FE%20Chromadex%20Corp&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Chromadex-Corp&v=1772647476535 "Chart of the company's future (projected) P/E Chromadex Corp")
Future (projected) P/E of the market segment - Medical instruments
ChromaDex Corp, through its Niagen brand, markets an ingredient for increasing NAD+ levels in the body, which is associated with cellular metabolism and healthy aging. This market segment is focused on nutraceuticals and dietary supplements. The chart reflects expectations for the sector, allowing one to assess the degree to which investors believe in the scientific basis and commercial potential of the company's product compared to other manufacturers.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772647476642 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
ChromaDex Corp (through the Niagen brand) commercializes nicotinamide riboside, a substance associated with healthy aging. The company operates at the intersection of science and the consumer market. This general sentiment graph shows how willing consumers and investors are to invest in innovative health and longevity products.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772647476708 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Chromadex Corp
ChromaDex Corp., through its Niagen product, focuses on ingredients for healthy aging. The company's profits depend on sales of this component to dietary supplement manufacturers and end consumers. This chart shows how successfully the company is commercializing its scientific developments in the growing longevity and healthy lifestyle industry.
Profit of companies in the market segment - Medical instruments
Chromadex Corp. focuses on the science of aging, promoting its key ingredient, Niagen, to boost cellular NAD+ levels. This profitability chart for the medical devices and nutraceuticals sector reflects the growing interest in healthy longevity. The growth in the chart indicates consumers' willingness to invest in science-based health products, which is the core of their business.
Overall market profit
ChromaDex Corp., known for its cellular energy-boosting product Niagen, operates at the intersection of nutraceuticals and biotechnology. Rising affluence, driven by rising corporate profits, is driving consumer demand for health and longevity products. This chart illustrates the overall financial environment in which consumers are willing to invest in their well-being.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Chromadex Corp
ChromaDex is the company behind Niagen, a patented form of nicotinamide riboside (NR), an ingredient for healthy aging. Its success depends on growing sales of dietary supplements and licensing. This chart reflects analyst expectations for consumer demand and distribution network expansion, which drives future profits.
%20profit%20of%20the%20company%20Chromadex%20Corp&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Chromadex-Corp&v=1772647477218 "Graph of future (projected) profit of the company Chromadex Corp")
Future (predicted) profit of companies in the market segment - Medical instruments
ChromaDex Corp. focuses on healthy aging and is a pioneer in research into nicotinamide riboside (NR), a component of its Niagen product. The company's success depends on growing consumer demand for nutraceuticals. This chart shows projected profitability for the biotech segment, reflecting overall trends in consumer health and longevity science.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772647477288 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
Chromadex Corp., a manufacturer of ingredients for healthy aging, operates in the consumer goods market. Demand for its products depends on discretionary spending. This graph, which reflects economic profit expectations, is an indicator of consumers' willingness to spend on dietary supplements and health products beyond basic needs.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772647477324 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Chromadex Corp
ChromaDex Corp is a pioneer in the study of nicotinamide riboside (NR), a component that promotes healthy aging. The chart shows the premium investors pay for each dollar of sales of its Niagen product. This reflects confidence in the company's scientific foundation and the enormous growth potential in the global nutraceutical and longevity supplement market.
P/S market segment - Medical instruments
ChromaDex Corp., through its flagship product Niagen, focuses on health and longevity at the cellular level. The company's revenue is derived from sales of nutraceuticals and ingredients. This chart reflects the average valuation in the biosciences industry, allowing investors to understand the market's confidence in the scientific basis and commercial prospects of ChromaDex's products.
P/S of the market as a whole
ChromaDex is a company focused on healthy aging research, best known for its ingredient Niagen (nicotinamide riboside). This chart, showing the average price-to-sales ratio for the entire market, helps assess the premium investors are willing to pay for scientific advancements and the growth potential of the dietary supplement and nutraceutical market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Chromadex Corp
ChromaDex is the company behind Niagen, a patented form of nicotinamide riboside, a cellular health component. Its business is longevity science. This chart shows how investors estimate the product's future sales, betting on the growing popularity of healthy aging supplements and expanding scientific evidence of their effectiveness.
%20P%2FS%20Chromadex%20Corp&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Chromadex-Corp&v=1772647477427 "The graph of the company's future (projected) P/S Chromadex Corp")
Future (projected) P/S of the market segment - Medical instruments
ChromaDex Corp is a healthy aging research company best known for its product Niagen, which increases NAD levels. This chart shows average revenue projections for the medical and nutraceutical products sector. It allows you to assess how the market perceives ChromaDex's potential in the growing longevity industry compared to its competitors.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772647477458 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
Chromadex Corp., through its flagship product Niagen, focuses on increasing levels of the coenzyme NAD+, which plays a key role in cellular metabolism and slowing aging. This graph reflects market expectations for future revenue. The company's success is driven by the growing global market for dietary supplements and healthy longevity products, a powerful consumer trend.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772647477557 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Chromadex Corp
This chart shows sales of Chromadex Corp., the company behind Niagen, a patented form of nicotinamide riboside, an ingredient in products that support healthy aging. Revenue is generated from sales of this component to supplement manufacturers and their own products. The trend reflects growing consumer interest in nutraceuticals and longevity science.
Sales of companies in the market segment - Medical instruments
Chromadex Corp, operating under the Niagen brand, focuses on nutraceutical products for healthy aging based on nicotinamide riboside (NR). This chart reflects the growth of the dietary supplement and functional food market. The company is a pioneer in its niche, and its scientific research and marketing directly drive demand for longevity-enhancing products.
Overall market sales
Chromadex Corp., known for its Niagen product, operates in the nutraceuticals and healthy aging space. Demand for these products depends on consumer discretionary spending. This aggregate sales chart is an indicator of purchasing power, which allows people to spend money on improving their quality of life and health.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Chromadex Corp
NAGE (ChromaDex) is the company behind Niagen, a patented form of vitamin B3 that promotes healthy aging. Future sales depend on the growing popularity of nutraceuticals and expanded distribution. The chart shows analysts' assessments of the longevity supplement market potential.
%20sales%20of%20the%20company%20Chromadex%20Corp&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Chromadex-Corp&v=1772647477649 "Schedule of future (projected) sales of the company Chromadex Corp")
Future (projected) sales of companies in the market segment - Medical instruments
Chromadex Corp., known for its product Niagen (nicotinamide riboside), operates in the healthy aging and cellular metabolism industries. The company's success depends on scientific research and growing consumer demand for nutraceuticals. This chart shows the outlook for the medical supplements and ingredients market, where Chromadex aims to strengthen its scientific and market position.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772647477682 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Chromadex Corp. focuses on healthy aging products based on the ingredient Niagen. The company's success hinges on the healthy lifestyle trend and consumers' willingness to spend on dietary supplements. This chart reflects overall consumer spending, and Chromadex's sales demonstrate the strength of the niche but growing longevity market, which is part of the wellness economy.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772647477713 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Chromadex Corp
Chromadex Corp. is focused on commercializing its healthy aging ingredient, Niagen. Its profitability depends on the growth of this product's sales, both directly to consumers and through partners. This chart illustrates how successfully the company is building a brand around its key molecule and translating scientific research into a high-margin commercial product.
Market segment marginality - Medical instruments
ChromaDex is a bioscience company focused on the research and commercialization of nicotinamide riboside (NR), a healthy aging ingredient sold under the Niagen brand. Profitability depends on growing consumer demand and scientific evidence of the product's effectiveness. This chart shows operating results. A comparison with other nutraceutical companies highlights their niche.
Market marginality as a whole
ChromaDex is the company behind Niagen, a patented form of nicotinamide riboside that promotes cellular metabolism and healthy aging. Their business operates at the intersection of science and consumer products. This overall profitability chart illustrates the state of the market, but ChromaDex's success depends more on scientific evidence and the marketing of their unique health products.
Employees in the company, segment and market as a whole
Number of employees in the company Chromadex Corp
Chromadex is the company behind the popular nutritional supplement Niagen, which promotes healthy aging. Its team focuses on scientific research, marketing, and brand management. The growth in this chart reflects investments in promoting its flagship product and expanding its global presence.
Share of the company's employees Chromadex Corp within the market segment - Medical instruments
ChromaDex is a pioneer in aging science, known for its key ingredient, Niagen, which boosts NAD+ levels. This chart shows the company's talent pool in the nutraceuticals niche. It reflects the size of the team of scientists and marketers who not only research health benefits but also create a global market for their innovative products aimed at healthy longevity.
Number of employees in the market segment - Medical instruments
ChromaDex Corp, known for its product Niagen, focuses on healthy aging and cellular metabolism. This chart illustrates employment trends in the nutraceuticals and biosciences sector. The growing number of researchers and marketing specialists in this niche reflects the growing global interest in products that support health and longevity at the cellular level and scientific breakthroughs in this field.
Number of employees in the market as a whole
ChromaDex is the science company behind Niagen, a patented form of nicotinamide riboside, a key ingredient for boosting cellular energy and healthy aging. Its success depends on research and consumer demand for dietary supplements. This chart illustrates how the growing nutraceutical and biotech market is creating new jobs in science, marketing, and manufacturing.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Chromadex Corp (NAGE)
ChromaDex Corp is the manufacturer of Niagen, a patented form of vitamin B3. This chart reflects the valuation of its intellectual capital and brand. The company's value lies not in its production capacity, but in its patents for Niagen, scientific research confirming its benefits, and brand strength. The chart shows the high market valuation of this IP and brand per employee.
%20of%20the%20company%20Chromadex%20Corp%20(NAGE)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Chromadex-Corp-NAGE&v=1772647478019 "Chart of market capitalization per employee (in thousands of dollars) of the company Chromadex Corp (NAGE)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Chromadex focuses on developing healthy aging products based on the ingredient Niagen. The company's business is built on scientific research and patents. This chart shows how the market values the intellectual property and growth potential of the company's products, where a small team of scientists and marketers is building a global brand.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772647478026 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
ChromaDex is a company focused on healthy aging research, best known for its ingredient Niagen (nicotinamide riboside). This chart shows how the market values a business built on science and intellectual property. Value is created through patents and clinical research, not a large staff.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772647478059 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Chromadex Corp (NAGE)
Chromadex (Niagen) is the company behind the Niagen (NR) brand, a popular supplement for "healthy aging." It's a consumer health (nutraceutical) company. This chart illustrates the effectiveness of their model: the company focuses on marketing and distribution (primarily e-commerce) of a science-based product, while outsourcing manufacturing.
%20Chart%20Chromadex%20Corp%20(NAGE)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Chromadex-Corp-NAGE&v=1772647478073 "Company Profit Per Employee (in thousands of dollars) Chart Chromadex Corp (NAGE)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
NAGE (Chromadex Corp) is the biomedical company behind Niagen (nicotinamide riboside), a popular supplement for "healthy aging." This metric reflects how successfully the company can sell its patented ingredient (B2B) and its own brand, Tru Niagen (D2C), in the highly competitive supplement market.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772647478092 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
Chromadex Corp (NAGE) is the company behind the Tru Niagen brand (NR component), marketed as a supplement for "healthy aging." It's a CPG/nutraceutical business. This chart shows how their marketing and R&D (clinical research) enable them to sell their branded ingredient at a high markup per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772647478116 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Chromadex Corp (NAGE)
Chromadex is the company behind Niagen, a patented form of nicotinamide riboside, which is important for cellular metabolism. This chart shows the commercial success of its key product. The growth in revenue per employee indicates growing demand for Niagen from both consumers and dietary supplement and food manufacturers.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Chromadex-Corp-NAGE&v=1772647478154 "Sales chart per company employee Chromadex Corp (NAGE)")
Sales per employee in the market segment - Medical instruments
ChromaDex is the company behind the popular nutraceutical Niagen (a "healthy aging" ingredient). This chart shows how effectively their team—from scientists to marketers—generates sales for this product. It compares ChromaDex's revenue per employee with the average for its competitors in the biotech and dietary supplements segment.
Sales per employee for the market as a whole
Chromadex (NAGE) focuses on the science of aging, promoting its key ingredient, Niagen (a form of vitamin B3), as the basis for dietary supplements. Their business consists of R&D, patents, and marketing. This chart demonstrates how successfully a science-intensive business model, supported by a small team of scientists and marketers, can generate revenue from the sale of patented ingredients and finished products.
Short shares by company, segment and market as a whole
Shares shorted by company Chromadex Corp (NAGE)
Chromadex Corp., a company operating under the Niagen brand, produces and sells nicotinamide riboside (NR) supplements associated with "healthy aging." This chart highlights bearish bets. Investors may doubt the scientific validity of NR's benefits, the company's ability to protect its patents, or its high valuation in the competitive supplement market.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Chromadex-Corp-NAGE&v=1772647478233 "Short Shares Chart for the Company Chromadex Corp (NAGE)")
Shares shorted by market segment - Medical instruments
ChromaDex (NAGE) is the company behind Niagen, a patented form of nicotinamide riboside (NR) marketed as a "healthy aging" supplement. This chart shows skepticism. "Shorts" here are betting that their product is ineffective, that their sales will stagnate, or that they will lose the patent disputes.
Shares shorted by the overall market
ChromaDex (NAGE), likely ticker NRDC or CDXC. ChromaDex is believed to produce Niagen (nicotinamide riboside), a supplement ingredient marketed as an anti-aging agent. This chart demonstrates skepticism of "anti-aging pills." Those who are "bears" either don't believe the scientific evidence supporting their product's effectiveness or believe the supplement market is too crowded for them to stand out.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Chromadex Corp (NAGE)
ChromaDex (Niagen Bioscience) produces the ingredient nicotinamide riboside (NR), marketed as an anti-aging ingredient. The business depends on consumer demand for dietary supplements. This chart, above 70, may reflect hype around NR. A level below 30 indicates doubts about its effectiveness or a decline in demand for dietary supplements.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Chromadex-Corp-NAGE&v=1772647478388 "RSI 14 indicator chart for the company's stock Chromadex Corp (NAGE)")
RSI 14 Market Segment - Medical instruments
ChromaDex (NAGE) is the company behind Niagen (NR), a popular dietary supplement that claims to boost NAD+ levels (anti-aging). The RSI_14_Seg for their segment (dietary supplements/medtech) shows the "temperature." It helps us understand whether NAGE's volatility is their science or just general hype in the sector.
RSI 14 for the overall market
Chromadex (NAGE) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NAGE (Chromadex Corp)
Chromadex Corp (NAGE) is a bioscience company known for its patented ingredient Niagen (nicotinamide riboside, form B3), which is promoted as a supplement for "healthy aging." This chart shows the average analyst forecast. Their price targets are based on Niagen sales growth (both as an ingredient and as a supplement, Tru Niagen) and clinical trial results.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NAGE-Chromadex-Corp&v=1772647478540 "A chart showing analyst consensus forecasts for the expected stock price. NAGE (Chromadex Corp)")
The difference between the consensus estimate and the actual stock price NAGE (Chromadex Corp)
Chromadex (NAGE) is the company behind Niagen (NR, a form of vitamin B3), a popular healthy aging supplement that claims to boost NAD+ levels. This chart shows their R&D score. It measures the gap between the price and the consensus target, reflecting whether analysts believe in the scientific and commercial prospects of their longevity molecule.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NAGE-Chromadex-Corp&v=1772647478578 "A chart showing the difference between the consensus forecast and the actual stock price. NAGE (Chromadex Corp)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
Niagen Bioscience (NAGE/NRGC) is the company behind Niagen, a patented form of nicotinamide riboside (NR), a supplement for "healthy aging" and boosting NAD+ levels. This chart shows general expectations for the medical devices/nutraceuticals sector. It reflects whether experts believe the anti-aging supplement market will grow.
Analysts' consensus forecast for the overall market share price
Chromadex (NAGE) is the biochemical company behind the youth elixir Niagen (nicotinamide riboside). They promote it as a cellular health supplement (NAD+). This chart shows the general sentiment of experts. It reflects the extent to which analysts believe consumers are willing to spend money on science-based wellness and longevity products.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Chromadex Corp
ChromaDex is a company behind longevity science. Their flagship product is Tru Niagen, a patented form of vitamin B3 (NR), which they claim boosts NAD+ levels (the key to anti-aging). This chart is a barometer of their commercialization. It likely reflects their direct-to-consumer sales, their business-to-business contracts (for example, with Nestlé), and the market's confidence in their scientific data.
AKIMA Market Segment Index - Medical instruments
ChromaDex (NAGE) is a single-product biotech; the company is a pioneer in aging science and holds a patent on the ingredient Niagen (NR), a precursor to NAD+, which it markets as a dietary supplement. This summary metric evaluates R&D. The graph shows the average value for the segment. This is a benchmark: how does this niche (dietary supplement) model (NAGE) differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
ChromaDex is a scientific nutraceutical company known for its ingredient Niagen (nicotinamide riboside) for healthy aging. This chart, reflecting the market average, provides context. It helps us understand how this growth story in the dietary supplement sector, driven by consumer demand for longevity, compares to overall macroeconomic trends.
